Platinum-based Chemotherapy
Veliparib + Chemoradiation for Advanced Non-Small Cell Lung Cancer
Recruiting0 awardsPhase 1 & 2
Anchorage, Alaska
This trial is studying the side effects and best dose of veliparib when given with radiation therapy, carboplatin, and paclitaxel to see how well it works in treating patients with stage III non-small cell lung cancer.
Radiation Therapy
Combined Chemoradiotherapy for Non-Small Cell Lung Cancer
Recruiting1 award5 criteria
Los Angeles, California
This trial is testing a new way to give radiation and chemotherapy to patients with stage II-III NSCLC that can't be removed by surgery. The new way may kill more tumor cells and spare more healthy tissue.
Topoisomerase II inhibitors
Chemotherapy + Radiation + Bevacizumab for Lung Cancer
Recruiting1 awardPhase 2
Mobile, Alabama
This trial is testing a combination of chemotherapy drugs, radiation therapy, and the drug bevacizumab in treating patients with newly diagnosed stage III non-small cell lung cancer.
Procedure
Reinforced vs Non-Reinforced Staple Lines for Lung Cancer
Recruiting1 awardPhase 1
Surrey, B.C
"This trial aims to determine if reinforced staplers are more effective at reducing prolonged air leaks and complications after lung surgery compared to standard staplers. Reinforced staplers, which have special materials like polygly
Antibody-drug conjugate
AZD5335 for Cancer
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is testing a new treatment called AZD5335, which combines an antibody with a cancer-killing drug. It aims to see if this treatment is safe and effective for patients with advanced solid tumors. The antibody helps deliver the drug directly to the cancer cells, potentially reducing harm to healthy cells.
Popular Filters
Trials for LUAD Patients
Platinum-containing Compound
Radiation + Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2 & 3
Boston, Massachusetts
This trial is testing the addition of radiation therapy to the usual immunotherapy (with or without chemotherapy) treatment for patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (advanced) or has spread to other places in the body (metastatic) and who are also negative for a molecular marker called PD-L1.
Cancer Vaccine
PD1-Vaxx Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Phoenix, Arizona
This trial tests IMU-201 (PD1-Vaxx), a new treatment for adults with Non-Small Cell Lung Cancer. It aims to help the immune system create antibodies to fight cancer cells more effectively and safely than current treatments.
CAR T-cell Therapy
IL13Ralpha2 CAR T Cells for Advanced Skin Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial tests the safety and best dose of modified immune cells for patients with advanced melanoma or other cancers that have spread. The treatment uses the patient's own T cells, which are changed in a lab to better attack cancer cells. The goal is to see if these modified cells can safely and effectively fight the cancer.
New Treatment Protocol for Advanced Lung Cancer
Recruiting1 award6 criteria
Columbus, Ohio
This trial tests new ways to treat advanced lung cancer using genetic and immune system tests, along with expert advice for doctors. It aims to improve survival and quality of life for patients with stage IV non-small cell lung cancer.
Trials for Non-Small Cell Lung Cancer Patients
Platinum-containing Compound
Radiation + Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2 & 3
Boston, Massachusetts
This trial is testing the addition of radiation therapy to the usual immunotherapy (with or without chemotherapy) treatment for patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (advanced) or has spread to other places in the body (metastatic) and who are also negative for a molecular marker called PD-L1.
Cancer Vaccine
PD1-Vaxx Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Phoenix, Arizona
This trial tests IMU-201 (PD1-Vaxx), a new treatment for adults with Non-Small Cell Lung Cancer. It aims to help the immune system create antibodies to fight cancer cells more effectively and safely than current treatments.
New Treatment Protocol for Advanced Lung Cancer
Recruiting1 award6 criteria
Columbus, Ohio
This trial tests new ways to treat advanced lung cancer using genetic and immune system tests, along with expert advice for doctors. It aims to improve survival and quality of life for patients with stage IV non-small cell lung cancer.
Alkylating agent
Chemotherapy + Radiation +/− Metformin for Lung Cancer
Recruiting1 awardPhase 2
Tuscaloosa, Alabama
This trial is comparing two ways of treating patients with stage III non-small cell lung cancer with chemotherapy and radiation. One group of patients will also receive metformin hydrochloride, a drug that may help to keep the tumors from coming back. It is not yet known if this combination of treatments is more effective than just chemotherapy and radiation alone.
Trials With No Placebo
Platinum-containing Compound
Radiation + Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2 & 3
Boston, Massachusetts
This trial is testing the addition of radiation therapy to the usual immunotherapy (with or without chemotherapy) treatment for patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (advanced) or has spread to other places in the body (metastatic) and who are also negative for a molecular marker called PD-L1.
Cancer Vaccine
PD1-Vaxx Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Phoenix, Arizona
This trial tests IMU-201 (PD1-Vaxx), a new treatment for adults with Non-Small Cell Lung Cancer. It aims to help the immune system create antibodies to fight cancer cells more effectively and safely than current treatments.
CAR T-cell Therapy
IL13Ralpha2 CAR T Cells for Advanced Skin Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial tests the safety and best dose of modified immune cells for patients with advanced melanoma or other cancers that have spread. The treatment uses the patient's own T cells, which are changed in a lab to better attack cancer cells. The goal is to see if these modified cells can safely and effectively fight the cancer.
New Treatment Protocol for Advanced Lung Cancer
Recruiting1 award6 criteria
Columbus, Ohio
This trial tests new ways to treat advanced lung cancer using genetic and immune system tests, along with expert advice for doctors. It aims to improve survival and quality of life for patients with stage IV non-small cell lung cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.